INTEGRA, BioTools and Sullivan Nicolaides Pathology work together to accelerate COVID-19 testing

The global COVID-19 pandemic has placed unprecedented demands on pathology services to test patient samples for the novel SARS-CoV-2 coronavirus alongside their pre-existing respiratory virus panels. This extreme influx of samples quickly exhausted the capacity of existing systems in the Microbiology and Molecular Pathology Department at Sullivan Nicolaides Pathology (SNP) – part of the Sonic Healthcare Group – in Brisbane, Australia, creating a clear need for additional automated liquid handling instruments.

INTEGRA, BioTools and Sullivan Nicolaides Pathology  work together to accelerate COVID-19 testing

INTEGRA’s Australian distributor, BioTools Pty Ltd, has partnered with SNP to support COVID-19 testing using the ASSIST PLUS pipetting robot, helping the laboratory team to increase sample processing capacity and fast track COVID-19 assay development while reducing manual processing. Using the ASSIST PLUS – in combination with a VOYAGER adjustable tip spacing pipette, Low Retention GripTips™ and SureFlo™ 10 ml Reagent Reservoirs – has enabled the lab to quickly develop and validate an automated pipetting protocol for PCR setup in low volume, 384 well plates. This miniaturization doubled the available testing capacity and simultaneously reduced consumption of expensive PCR reagents of dwindling availability, with associated cost savings.

SNP successfully validated the automated protocol against its existing manual processing method, performed using a handheld electronic pipette. The results were shown to be reproducible, precise and accurate, with no contamination observed in either the control or patient samples. The compact, easy-to-use ASSIST PLUS pipetting robot, complete with validated protocol, was fully deployed within five working days to support COVID-19 testing of patient samples and alleviate pressure on staff time.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2020, March 31). INTEGRA, BioTools and Sullivan Nicolaides Pathology work together to accelerate COVID-19 testing. News-Medical. Retrieved on June 06, 2020 from https://www.news-medical.net/news/20200331/INTEGRA-BioTools-and-Sullivan-Nicolaides-Pathology-work-together-to-accelerate-COVID-19-testing.aspx.

  • MLA

    INTEGRA Biosciences. "INTEGRA, BioTools and Sullivan Nicolaides Pathology work together to accelerate COVID-19 testing". News-Medical. 06 June 2020. <https://www.news-medical.net/news/20200331/INTEGRA-BioTools-and-Sullivan-Nicolaides-Pathology-work-together-to-accelerate-COVID-19-testing.aspx>.

  • Chicago

    INTEGRA Biosciences. "INTEGRA, BioTools and Sullivan Nicolaides Pathology work together to accelerate COVID-19 testing". News-Medical. https://www.news-medical.net/news/20200331/INTEGRA-BioTools-and-Sullivan-Nicolaides-Pathology-work-together-to-accelerate-COVID-19-testing.aspx. (accessed June 06, 2020).

  • Harvard

    INTEGRA Biosciences. 2020. INTEGRA, BioTools and Sullivan Nicolaides Pathology work together to accelerate COVID-19 testing. News-Medical, viewed 06 June 2020, https://www.news-medical.net/news/20200331/INTEGRA-BioTools-and-Sullivan-Nicolaides-Pathology-work-together-to-accelerate-COVID-19-testing.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Researchers use INTEGRA's VIAFLO 96/384 to streamline the experimental workflow